Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the third quarter ended September 30, 2020 before the US financial markets open on October 29, 2020.
BOSTON--(BUSINESS WIRE)-- Alexion Pharmaceuticals Inc., (Nasdaq: ALXN) today announced that the Company will report its financial results for the third quarter ended September 30, 2020 before the US financial markets open on October 29, 2020. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast from 8:00-9:00 a.m. Eastern Time (ET).
To participate in this conference call, dial (866) 762-3111 (USA) or (210) 874-7712 (International), conference ID 6582445 shortly before 8:00 a.m. ET. The audio webcast can be accessed on the Investor page of http://ir.alexion.com and an archived version will be available for a limited time following the presentation.
[ALXN-E]
View source version on businesswire.com: https://www.businesswire.com/news/home/20201020005859/en/
Contacts
Investors
Chris Stevo
Head of Investor Relations
(857) 338-9309
Source: Alexion Pharmaceuticals, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20201020005859/en
